10-Q: Nordson Reports Strong Q2 2026 Results, Sales Up 8.5%
Quarterly Report
Nordson Corporation announced its second quarter fiscal year 2026 results, with sales increasing 8.5% year-over-year to $740.8 million and diluted EPS rising 6.1% to $2.09.
Summary
- Nordson Corporation reported strong financial results for the second quarter of fiscal year 2026, ending April 30, 2026.
- Total sales increased by 8.5% to $740.8 million compared to the same period last year.
- Net income rose by 4.4% to $117.3 million, resulting in diluted earnings per share (EPS) of $2.09, a 6.1% increase from $1.97 in the prior year.
- For the first six months of fiscal year 2026, sales grew 8.6% to $1.41 billion, and net income increased by 21.1% to $250.7 million, with diluted EPS up 23.5% to $4.47.
- The Industrial Precision Solutions (IPS) segment saw a 9.9% sales increase, Medical and Fluid Solutions (MFS) increased by 5.0%, and Advanced Technology Solutions (ATS) grew by 10.1% for the quarter.
- A pension settlement charge of $24.0 million was recorded in the second quarter of 2026.
- The company maintained a strong liquidity position with $102.0 million in cash and cash equivalents and $1.05 billion in available borrowings.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive report, with strong sales and EPS growth, demonstrating effective execution and market demand, despite a notable pension settlement charge.
Positives
- Sales increased by 8.5% to $740.8 million for the three months ended April 30, 2026.
- Diluted earnings per share (EPS) increased by 6.1% to $2.09 for the three months ended April 30, 2026.
- Net income for the six months ended April 30, 2026, increased by 21.1% to $250.7 million.
- Diluted EPS for the six months ended April 30, 2026, increased by 23.5% to $4.47.
- Operating profit for the three months ended April 30, 2026, increased by 16.9% to $197.2 million.
- Operating profit for the six months ended April 30, 2026, increased by 17.4% to $363.6 million.
- The IPS segment showed organic sales growth of 5.0% for the quarter and 4.1% for the six months.
- The ATS segment demonstrated strong organic sales growth of 8.5% for the quarter and 13.8% for the six months.
- Gross margin remained strong at 54.5% for the quarter and 54.6% for the six months.
- The company repaid $107 million of debt and repurchased $129 million in common shares during the first six months of fiscal 2026.
- The company has a $1.2 billion revolving credit facility maturing in January 2031, with $295 million outstanding as of April 30, 2026, indicating ample liquidity.
Negatives
- A pension settlement charge of $24.0 million was incurred in the second quarter of fiscal year 2026, impacting net income.
- Other income (expense) - net for the three months ended April 30, 2026, was an expense of $10.4 million, compared to an expense of $4.0 million in the prior year, largely due to unrealized losses on minority investments.
- The MFS segment EBITDA decreased by 50 basis points for the quarter due to near-term product start-up headwinds.
- The IPS segment EBITDA decreased by 200 basis points for the six months due to unfavorable product and geographic mix in the first quarter.
Risks
- U.S. and international economic and political conditions could impact results.
- Currency exchange rates and devaluations pose a risk.
- Potential acquisitions and the company's ability to integrate them successfully are subject to risk.
- Divesting or disposing of businesses not fitting the strategic plan carries inherent risks.
- Changes in U.S. trade policy and tariffs could negatively affect the company.
- Changes in tax law present potential risks.
- Unforeseen events such as political unrest, acts of terror, natural disasters, and pandemics could impact operations.
- International conflicts and changes in trade policies, tariffs, and other import/export regulations could negatively impact cash flow and liquidity.
Future Outlook
The company's scalable growth framework is expected to deliver top-tier growth with leading margins and returns. Management believes the company is well-positioned to manage liquidity needs and has the ability to generate and obtain adequate cash to meet short-term and long-term needs. However, the impact of international conflicts, changes in trade policies, tariffs, and other import/export regulations could negatively impact cash flow from operations and liquidity in future periods.
Management Comments
- Nordson is an innovative precision technology company that leverages a scalable growth framework expected to deliver top tier growth with leading margins and returns.
- Our strategy for long-term growth is based on solving customers needs globally.
- The Company believes it has the ability to generate and obtain adequate amounts of cash to meet its short-term and long-term needs for cash.
Industry Context
StockSavvy.ai notes that Nordson's performance in precision dispensing and fluid management technologies aligns with broader industry trends favoring automation, efficiency, and advanced manufacturing processes across electronics, medical devices, and industrial applications. The company's diversified segment performance reflects resilience in varied end markets.
Comparison to Industry Standards
- Nordson's gross margin of approximately 54.5% is generally considered strong within the industrial manufacturing sector, often outperforming broader industrial conglomerates but potentially in line with specialized technology providers.
- The company's revenue growth of 8.5% for the quarter and 8.6% for the six months is robust, especially for a mature industrial company, suggesting effective market penetration and product innovation.
- Diluted EPS growth of 6.1% for the quarter and 23.5% for the six months indicates strong operational leverage and effective capital allocation, including share repurchases.
- The company's focus on specific segments like Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions allows for specialized market strategies that can yield higher margins and growth compared to diversified industrial players like 3M or Honeywell, which have broader product portfolios.
Legal Proceedings
- The company is involved in pending or potential litigation regarding environmental, product liability, patent, contract, employee, and other matters arising from the normal course of business. Management does not believe that losses exceeding accrued amounts would materially adversely affect the company's financial condition, operating results, or cash flows.
Stakeholder Impact
- Shareholders: Positive impact from increased net income, EPS growth, and ongoing share repurchase programs. Potential for continued dividend payments.
- Employees: Continued employment and potential for performance-based compensation. The company employs approximately 8,200 people worldwide.
- Creditors: The company maintains a strong liquidity position and is in compliance with debt covenants, indicating a low risk of default.
- Suppliers: Continued business operations and demand for materials and components, supporting supplier relationships.
Next Steps
- Continue to leverage scalable growth framework for top-tier growth with leading margins and returns.
- Address near-term product start-up headwinds in the MFS segment.
- Manage potential impacts of international conflicts, trade policies, and regulations on cash flow and liquidity.
- Utilize available borrowing capacity and cash from operations to fund liquidity needs, capital expenditures, pension contributions, debt payments, dividends, and share repurchases.
Key Dates
| Date | Description |
|---|---|
| 2023-06-06 | Previous unsecured senior credit agreement dated, including a term loan facility and a multicurrency revolving credit facility. |
| 2023-09-09 | Senior Notes due 2029 offering completed. |
| 2023-09-13 | 5.600% Notes due 2028 and 5.800% Notes due 2033 offering completed. |
| 2024-09-09 | 4.500% Notes due 2029 offering completed. |
| 2025-01-31 | Interim period end for six months ended April 30, 2025. |
| 2025-02-01 | Date for retirees included in the U.S. pension plan settlement. |
| 2025-04-30 | End of the second quarter of fiscal year 2025. |
| 2025-10-31 | End of fiscal year 2025. |
| 2025-11-01 | Beginning of fiscal year 2026. |
| 2026-01-13 | Rule 10b5-1 trading plan adopted by Srinivas Subramanian. |
| 2026-01-16 | Rule 10b5-1 trading plan adopted by Joseph P. Kelley. |
| 2026-01-31 | Interim period end for six months ended April 30, 2026. |
| 2026-02-01 | Start of fiscal year 2026 for certain accounting standards. |
| 2026-02-06 | Rule 10b5-1 trading plan terminated by Sundaram Nagarajan. |
| 2026-02-10 | Rule 10b5-1 trading plan terminated by Joseph P. Kelley. |
| 2026-04-30 | End of the second quarter of fiscal year 2026. |
| 2026-05-19 | Date as of which the number of outstanding common shares is reported. |
| 2026-05-21 | Date of the report and certifications. |
| 2028-12-01 | Restriction on selling shares in a minority interest investment expires. |
| 2031-01-01 | Maturity date of the new Revolving Credit Agreement. |
Recommendation
holdThe company delivered strong results with increased sales and EPS, demonstrating operational strength and effective management. However, the pension settlement charge and ongoing geopolitical/trade policy risks warrant a cautious approach. While positive, the current performance is largely in line with expectations for a company of Nordson's caliber, suggesting a 'hold' rating until further catalysts or significant shifts in risk factors emerge.
Keywords
Nordson Corporation, Form 10-Q, Quarterly Report, Financial Results, Sales, Net Income, Earnings Per Share, Industrial Precision Solutions, Medical and Fluid Solutions, Advanced Technology Solutions, EBITDA, Liquidity, Debt Repayment, Share Repurchase, Pension Settlement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.